Cornell Pochily Investment Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$249K Buy
+1,574
New +$213K 0.07% 168
2026
Q1
Sell
-1,359
Closed -$166K 189
2025
Q4
$166K Buy
+1,359
New +$156K 0.05% 182
2024
Q4
Sell
-2,046
Closed -$202K 180
2024
Q3
$202K Sell
2,046
-115
-5% -$11.3K 0.07% 175
2024
Q2
$200K Sell
2,161
-20
-0.9% -$1.79K 0.08% 166
2024
Q1
$207K Sell
2,181
-439
-17% -$40.7K 0.08% 167
2023
Q4
$234K Buy
+2,620
New +$195K 0.1% 159
2023
Q3
Sell
-2,590
Closed -$215K 174
2023
Q2
$215K Buy
+2,590
New +$217K 0.09% 159
2023
Q1
Sell
-2,562
Closed -$213K 170
2022
Q4
$213K Hold
2,562
0.1% 165
2022
Q3
$203K Buy
+2,562
New +$216K 0.09% 161
2021
Q4
Sell
-2,292
Closed -$288K 168
2021
Q3
$288K Buy
+2,292
New +$295K 0.12% 141
2021
Q1
Sell
-2,244
Closed -$316K 154
2020
Q4
$316K Buy
+2,244
New +$287K 0.15% 122
2020
Q3
Sell
-2,543
Closed -$285K 147
2020
Q2
$285K Buy
+2,543
New +$250K 0.18% 108
2020
Q1
Sell
-2,517
Closed -$239K 139
2019
Q4
$239K Sell
2,517
-140
-5% -$12.1K 0.14% 125
2019
Q3
$203K Hold
2,657
0.13% 129
2019
Q2
$233K Buy
2,657
+50
+2% +$4.26K 0.06% 138
2019
Q1
$236K Buy
+2,607
New +$222K 0.16% 116

Other funds holding XBI

Cornell Pochily Investment Advisors's XBI Position: Q2 2026 in Review

Cornell Pochily Investment Advisors opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 1,574 shares worth $249K. The stake represents 0.07% of the portfolio and ranks #168 among its holdings. This is a return to the name: Cornell Pochily Investment Advisors previously reported a position in XBI as recently as Q4 2025.

Cornell Pochily Investment Advisors first reported a position in XBI in Q1 2019 and has held it in 16 quarters since. The position peaked at $316K in Q4 2020. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Cornell Pochily Investment Advisors held 1,574 shares of State Street SPDR S&P Biotech ETF worth $249K as of Q2 2026.
  • State Street SPDR S&P Biotech ETF was a new Cornell Pochily Investment Advisors position in Q2 2026.
  • State Street SPDR S&P Biotech ETF made up 0.07% of Cornell Pochily Investment Advisors's portfolio in Q2 2026, its #168 holding.
  • Cornell Pochily Investment Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q1 2019 and has held it in 16 quarters since.
  • Cornell Pochily Investment Advisors's State Street SPDR S&P Biotech ETF position peaked at $316K in Q4 2020.
  • 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Cornell Pochily Investment Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.